Education
About Us
Working with TipRanks
Follow Us
Sinovac Biotech (SVA)
NASDAQ:SVA
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 448.27M | $ 1.49B | $ 19.37B | $ 510.62M | $ 246.05M |
| Gross Profit | $ 266.75M | $ 808.30M | $ 18.30B | $ 443.44M | $ 213.58M |
| Operating Income | $ -546.72M | $ -466.07M | $ 17.55B | $ 215.64M | $ 68.56M |
| EBITDA | $ -6.03M | $ 183.10M | $ 17.65B | $ 221.76M | $ 76.05M |
| Net Income | $ -99.92M | $ 113.87M | $ 8.47B | $ 110.37M | $ 44.93M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 11.22B | $ 11.31B | $ 13.42B | $ 1.18B | $ 202.99M |
| Total Assets | $ 13.66B | $ 14.11B | $ 16.75B | $ 1.90B | $ 452.30M |
| Total Debt | $ 298.98M | $ 74.67M | $ 144.91M | $ 136.39M | $ 20.27M |
| Net Debt | $ -971.15M | $ -4.20B | $ -11.46B | $ -904.62M | $ -132.45M |
| Total Liabilities | $ 1.64B | $ 1.40B | $ 2.87B | $ 781.20M | $ 100.10M |
| Stockholders' Equity | $ 8.71B | $ 8.92B | $ 9.33B | $ 746.47M | $ 294.02M |
| Cash Flow | |||||
| Free Cash Flow | $ -41.69M | $ -1.17B | $ 14.63B | $ 351.66M | $ 28.45M |
| Operating Cash Flow | $ 104.00M | $ -770.75M | $ 15.35B | $ 479.31M | $ 39.07M |
| Investing Cash Flow | $ -2.93B | $ -5.76B | $ -3.02B | $ -204.76M | $ -42.45M |
| Financing Cash Flow | $ -76.06M | $ -241.40M | $ -1.90B | $ 592.57M | $ 1.74M |
Sinovac Biotech Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.